Navigation Links
Immune Response May Hinder Stem Cell Treatments
Date:8/18/2008

This unexpected reaction must be overcome to ensure therapeutic success, experts say

MONDAY, Aug. 18 (HealthDay News) -- Human embryonic stem cells trigger an immune response in mice, a new study finds. If the same thing happens in humans, it could prove a big roadblock to stem cell-based treatments, researchers say.

Researchers at Stanford University School of Medicine found that common anti-rejection medications could counter the mice's immune response. However, the new finding dashes prior hopes that the immune system gave foreign embryonic stem cells a "free pass" through the body.

"It's getting harder and harder to believe that these cells are immunoprivileged," senior author Dr. Joseph Wu, assistant professor of cardiovascular medicine and of radiology at Stanford, said in a news release issued by the university. "In fact, the rejection of these cells confirms our suspicions that they do cause an immune response."

The findings were to be published in the Aug.18 online edition of the journal Proceedings of the National Academy of Sciences.

Embryonic stem cells form all cells in an embryo. Many researchers have suggested that the immune system ignores them to allow the growth of a fetus that contains both maternal and paternal genetic material. Such an immunological exemption would counter concerns about using cells therapeutically that don't exactly match the recipient's immune system.

After injecting human embryonic stem cells into mice, those cells died within 10 days in mice with good immune systems but survived and multiplied in the mice with impaired immune responses. Further injections into the normally functioning mice led to more rapid cell death, a sign that the mice's immune system was getting better at recognizing and rejecting the cells.

"The data is quite convincing," Wu said. "Based on these results, we believe that transplanting these cells into humans would also cause an immune response."

Medicating the mice with normal immune systems with a combination of two common anti-rejection compounds -- tacrolimus and sirolimus -- allowed those cells to survive for up to 28 days, the team said.

More information

The U.S. National Institutes of Health has more about stem cells.



-- Kevin McKeever



SOURCE: Stanford University School of Medicine, news release, Aug. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. Immune deficiency linked to a type of eye cancer
3. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
4. Melanoma drug revs immune cells but cancer cells ignore it
5. Study identifies key player in the bodys immune response to chronic stress
6. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
7. UVA researchers find important clue to immune infertility
8. M.D. Anderson-led team reports possible key to autoimmune disease
9. Their immune cells, fighting your cancer
10. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
11. Occupational exposures may be linked to death from autoimmune disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune Response May Hinder Stem Cell Treatments
(Date:5/3/2016)... ... May 04, 2016 , ... Safety ... global construction firms representing the Construction Industry Safety Initiative (CISI) and the Incident ... purpose: to inspire everyone in the industry to be leaders in safety. Statistics ...
(Date:5/3/2016)... ... May 04, 2016 , ... The National Association ... into its VIP Woman of the Year Circle. She is recognized with this prestigious ... professional women, boasting more than 850,000 members and over 200 operating Local Chapters. , ...
(Date:5/3/2016)... ... May 03, 2016 , ... According to an article ... issues related to medical care in the hospital setting, which include excessive wait ... hospital staff. Commenting on this article, the founder of House Call Doctor Los ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... 2016 Champion Award to Charles D. Pulido, R.Ph., Co-Founder of NCPDP and member ... Ph.D., Pharmacy Advisor and Health IT Specialist, Office of the National Coordinator for ...
(Date:5/3/2016)... Redondo Beach, CA (PRWEB) , ... May 03, 2016 , ... ... together online to help cancer patients and their families move toward recovery and is ... the focus of today's Dr. Carol Francis Talk Radio show considering medical ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... YORK , May 2, 2016 Kalorama ... EMR (Electronic Medical Records) market in a recent white ... sales, vendor switches, Increased physician usage, a growing market are ... were noted in Kalorama,s report EMR 2016: ... report marks Kalorama,s seventh complete study of the EMR ...
(Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology: